Financial Snapshot

Revenue

TTM

$8.006M

Gross Margin

Last 4 Quarters

N/A

Net Income

TTM

-$5.718M

Current Assets

2023 Q4

$11.55M

Current Liabilities

2023 Q4

$1.656M

Current Ratio

2023 Q4

697.58%

Total Assets

2023 Q4

$11.59M

Total Liabilities

2023 Q4

$1.656M

Book Value

2023 Q4

$9.930M

Cash

2023 Q4

$10.90M

P/E

Last 4 Quarters

N/A

Free Cash Flow

TTM

$1.957M

Stock Price

Market Cap: $4.2709 Million

About Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. The company is headquartered in Boulder, Colorado and currently employs 4 full-time employees. The firm is in the process of dissolution.

Industry: Biological Products, (No Diagnostic Substances) Peers: POLARITYTE, INC. NUTRA PHARMA CORP LadRx Corp Kiromic Biopharma, Inc. MANHATTAN SCIENTIFICS INC Revelation Biosciences Inc Scopus BioPharma Inc.